Hoffman Michael B
CIK 0001290208
Chairman and CEODirector10% Owner
Filings
19
Latest May 29, 2026
Issuers covered
2
Showing
19 of 19
Page 1
Track record
15 of 18 open-market trades scored (83% price coverage) - 3 issuers without price data. Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 15 | 27% | +7.8% | -10.5% | +142.9% | -10.5% |
| 90 days | 14 | 14% | -31.5% | -41.6% | +41.0% | -41.6% |
| 180 days | 12 | 0% | -42.0% | -49.6% | -5.1% | -49.6% |
| 365 days | - | - | - | - | - | - |
Issuers
Companies where Hoffman Michael B has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| ANVS | Annovis Bio, Inc. | 18 | May 21, 2026 |
| TDAC | Translational Development Acquisition Corp. | 1 | May 29, 2026 |
All filings
19 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|